A carregar...
Blockage of the mevalonate pathway overcomes the apoptotic resistance to MEK inhibitors with suppressing the activation of Akt in cancer cells
With increasing clinical demands for MEK inhibitors in cancer treatment, overcoming the resistance to MEK inhibitors is an urgent problem to be solved. Numerous reports have shown that MEK inhibition results in the activation of PI3K-Akt signaling, which may confer apoptotic resistance to MEK inhibi...
Na minha lista:
Publicado no: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Impact Journals LLC
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5929411/ https://ncbi.nlm.nih.gov/pubmed/29731968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24696 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|